Post by Debiopharm

Name: 💡Glioblastoma (GBM) is the most common and aggressive brain tumor in adults, carrying a notoriously
Uploaded: 2026-05-28T14:30:01.622Z
Channel: Debiopharm
Description: 💡Glioblastoma (GBM) is the most common and aggressive brain tumor in adults, carrying a notoriously poor prognosis. Treating it comes with immense challenges from tumor heterogeneity to the blood-bra

46,269 followers

💡Glioblastoma (GBM) is the most common and aggressive brain tumor in adults, carrying a notoriously poor prognosis. Treating it comes with immense challenges from tumor heterogeneity to the blood-brain barrier blocking 98% of drugs. 🔬 We’re advancing research to find new ways to break through the blood brain barrier and treat cancer. 🎬 In this video interview with our Associate Medical Director Rita Paiva, learn more about the challenges in treating GBM and how our research with zedoresertib exploits a unique vulnerability in these cells. By inhibiting WEE1, we’re disrupting the cancer's DNA repair process to ultimately trigger tumor cell death. With the dose escalation phase showing a good safety profile and signals of anti-tumor activity, stay up-to-date as our research is ongoing! Learn more about our program 👇 https://lnkd.in/dp9NJ_cP #BrainCancer #Glioblastoma #ClinicalResearch #DDRi #DrugDevelopment

Video Content